483 Observations related to Inadequate Investigations
FDA 483 Observations Related to Inadequate Investigations in Pharmaceutical Manufacturing FDA Form 483 Observations Related to Inadequate Investigations in Pharmaceutical Manufacturing In the pharmaceutical industry, investigations are a critical component of the Quality Management System (QMS). Whether dealing with deviations, out-of-specification (OOS) results, customer complaints, environmental monitoring excursions, or product quality defects, a thorough and … Read more
